3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
7
Thyroid Neoplasms
3
Neoplasm Metastasis
2
Triple Negative Breast Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Hodgkin Disease
1
Endocrine Gland Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Adenoma, Islet Cell
1
Interventions
Bevacizumab
2
temsirolimus
1
niraparib
1
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Valproic Acid
1
Therapeutic Irrigation
1
Sunitinib
1
Staining and Labeling
1
Sirolimus
1
Psilocybin
1
Phlebotomy
1
Lutetium-177
1
Lutetium
1
Irinotecan
1
Immunoglobulin G
1
Gemcitabine
1
Etoposide
1
Disulfides
1
Diffusion
1
Cyclophosphamide
1
Cisplatin
1
Cetuximab
1
Capecitabine
1
Blood Specimen Collection
1
Biopsy, Large-Core Needle
1
Ascorbic Acid
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endocrine Gland Neoplasms
×
Biopsy, Large-Core Needle
×
Clear all
NCT07121998
2025-08-14
PROGRESS-TMZ
Uppsala University
Recruiting
94 enrolled